Pfizer (PFE) Dividends payables (2009 - 2025)

Pfizer (PFE) has 17 years of Dividends payables data on file, last reported at $2.4 billion in Q4 2025.

• Dividends payables for Q4 2025 came in at $2.4 billion, changed 0.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.4 billion (changed 0.33% YoY), and the FY2025 annual result was $2.4 billion, changed 0.33% from the prior year.
• Dividends payables steadied at $2.4 billion in Q4 2025 per PFE's latest filing, from $2.4 billion in the prior quarter.
• Over five years, Dividends payables peaked at $2.4 billion in Q2 2025 and troughed at $2.2 billion in Q3 2021.
• A 5-year average of $2.3 billion and a median of $2.3 billion in 2022 frame the typical range for Dividends payables.
• The sharpest annual moves came in 2021 and 2025: Dividends payables advanced 4.02% in 2021, then increased 0.33% in 2025.
• A 5-year view of Dividends payables shows it stood at $2.2 billion in 2021, then climbed by 2.4% to $2.3 billion in 2022, then increased by 3.0% to $2.4 billion in 2023, then advanced by 2.74% to $2.4 billion in 2024, then rose by 0.33% to $2.4 billion in 2025.
• Business Quant data shows PFE's Dividends payables at $2.4 billion in Q4 2025, $2.4 billion in Q2 2025, and $2.4 billion in Q4 2024.